Shigetsugu Ohgi1, Nagako Ohgi. 1. Department of Vascular Surgery, Hitachi Memorial Hospital, Yasugi, Shimane, Japan.
Abstract
OBJECTIVE: In patients with isolated soleal vein thrombosis (SVT), the relation between acute thrombi and positive anti-nuclear antibody (ANA) was investigated. SUBJECTS AND METHODS: The subjects were 116 lower extremities in 86 patients with SVT. They were diagnosed and examined by ultrasonography and blood serum analysis (D-dimer, ANA), and had been followed up every three months. RESULTS: They had acute SVT in 35 limbs (30%) and chronic SVT in 86 limbs (70%), and they had positive ANA in 63%. They had recurrent SVT in 26%, and all were positive for ANA. CONCLUSION: ANA-positivity might be a risk factor for acute thrombi in patients with SVT. (*English Translation of J Jpn Coll Angiol 2010; 50: 417-422.).
OBJECTIVE: In patients with isolated soleal vein thrombosis (SVT), the relation between acute thrombi and positive anti-nuclear antibody (ANA) was investigated. SUBJECTS AND METHODS: The subjects were 116 lower extremities in 86 patients with SVT. They were diagnosed and examined by ultrasonography and blood serum analysis (D-dimer, ANA), and had been followed up every three months. RESULTS: They had acute SVT in 35 limbs (30%) and chronic SVT in 86 limbs (70%), and they had positive ANA in 63%. They had recurrent SVT in 26%, and all were positive for ANA. CONCLUSION: ANA-positivity might be a risk factor for acute thrombi in patients with SVT. (*English Translation of J Jpn Coll Angiol 2010; 50: 417-422.).
Authors: M M Solis; T J Ranval; M L Nix; J F Eidt; C L Nelson; E J Ferris; R C Lavender; R W Barnes Journal: J Vasc Surg Date: 1992-09 Impact factor: 4.268
Authors: Mark H Meissner; Gregory Moneta; Kevin Burnand; Peter Gloviczki; Joann M Lohr; Fedor Lurie; Mark A Mattos; Robert B McLafferty; Geza Mozes; Robert B Rutherford; Frank Padberg; David S Sumner Journal: J Vasc Surg Date: 2007-12 Impact factor: 4.268